Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021956
Filing Date
2020-05-06
Accepted
2020-05-06 16:21:30
Documents
71
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20200331.htm 10-Q 1723103
2 EX-31.1 flgt-ex311_6.htm EX-31.1 19156
3 EX-31.2 flgt-ex312_7.htm EX-31.2 18864
4 EX-32.1 flgt-ex321_8.htm EX-32.1 18210
  Complete submission text file 0001564590-20-021956.txt   6022388

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flgt-20200331.xml EX-101.INS 1296069
6 XBRL TAXONOMY EXTENSION SCHEMA flgt-20200331.xsd EX-101.SCH 46457
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20200331_cal.xml EX-101.CAL 51312
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20200331_def.xml EX-101.DEF 115872
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20200331_lab.xml EX-101.LAB 344853
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20200331_pre.xml EX-101.PRE 258011
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 20852916
SIC: 8071 Services-Medical Laboratories